2seventy Bio Inc 's ROA from the first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is 2seventy Bio Inc 's ROA in the first quarter of 2025?
2seventy Bio Inc recorded a cumulative net loss of $-4 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -1.21%.

However, within the Healthcare sector 213 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2025 quarter, so far to 2726, from total ROA ranking in the fourth quarter of 2024 at 3914.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Total Assets Change	61.35 %	-21.72 %	-22.34 %	-31.93 %	-41.34 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-4	-57	-95	-156	-223
Return On Assets (TTM)	-1.21 %	-19.5 %	-30.29 %	-46.83 %	-60.35 %
TSVT's Total Ranking	# 2726	# 3914	# 3654	# 3902	# 4125
Total Assets (TTM) in million	480	269	299	309	297
Seq. Total Assets Change	78.51 %	-10 %	-3.25 %	3.81 %	-13.4 %
Seq. Net Income Change	-	-	-	-	-

TSVT's 5 Years Annual ROA >> Back to TSVT Management Effectiveness >> Compare TSVT ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 68
Sector	# 214
Overall	# 2689

Return On Assets Statistics
High	Average	Low
-0.83 %	-25.55 %	-37.58 %
(Mar 31 2025)		(Sep 30 2022)

Financial Statements
2seventy Bio Inc 's Assets	$ 480 million	TSVT's Balance sheet
2seventy Bio Inc 's Income	$ 0 million	Quarterly TSVT's Income Statement
TSVT's Income by Division		See TSVT's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	FY
Y / Y Total Assets Change	-21.72 %	-17.9 %	-14.01 %	-	-
Total Assets in million	269	344	418	487	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-57	-218	-254	-292	0
Annual Return On Assets	-21.29 %	-63.34 %	-60.75 %	-60.06 %	-

TSVT's 5 Years Annual ROA >> Back to TSVT Management Effectiveness >> Compare TSVT ROA to its Competitors

More Return On Assets Ratios
TSVT's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TSVT's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TSVT's Competitors
Subscribers only: Roa for 2seventy Bio Inc 's Suppliers
Subscribers only: Return On Assets for TSVT's Customers

You may also want to know
TSVT's Roi	TSVT's Inventory Turnover Ratio	TSVT's Growth Rates	TSVT's Dividend Comparisons
	TSVT's Profitability Ratios	TSVT's Asset Turnover Ratio	TSVT's Dividend Growth
TSVT's Roe	TSVT's Valuation Ratios	TSVT's Financial Strength Ratios	TSVT's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2025, within Healthcare Sector

ROA

Date modified: 2026-09-18T13:11:06+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.